Pancreatic Cancer Research

ResearcherBeijing University of Chinese MedicineActive in the last 2 years

Xing Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2665-6940; OpenAlex author ID A5100399153. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: 2 papers · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 7

  1. Current and projected incidence rates of pancreatic cancer in 43 countries: an analysis of the Cancer Incidence in Five Continents database. Last author DOI 10.1136/bmjgast-2024-001544↗
  2. Bioinformatics analyses of infiltrating immune cell participation on pancreatic ductal adenocarcinoma progression and in vivo experiment of the therapeutic eff… Co-author DOI 10.1016/j.jep.2023.117590↗
  3. Clinical Efficacy and Safety of Traditional Medicine Preparations Combined With Chemotherapy for Advanced Pancreatic Cancer: A Systematic Review and Meta-Analy… Co-author DOI 10.3389/fonc.2022.828450↗
  4. Study on the treatment of pancreatic cancer with integrated traditional Chinese and Western medicine: A study protocol of a multicenter prospective cohort stud… Co-author DOI 10.1097/md.0000000000017975↗
  5. Three hypomethylated genes were associated with poor overall survival in pancreatic cancer patients. Co-author DOI 10.18632/aging.101785↗
  6. Different Survival Benefits of Chinese Medicine for Pancreatic Cancer: How to Choose? Co-author DOI 10.1007/s11655-017-2971-1↗
  7. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validatio… First author DOI 10.1038/s41598-017-01904-z↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Baojin Hua · 4 shared papers, 2019–2025 · strength 0.65
  2. Juling Jiang · 3 shared papers, 2019–2024 · strength 0.42
  3. Rui Liu · 3 shared papers, 2019–2024 · strength 0.42
  4. Jiaqi Hu · 2 shared papers, 2022–2024 · strength 0.33
  5. Bo Pang · 1 shared paper, 2025 · strength 0.23
  6. Songting Shou · 1 shared paper, 2025 · strength 0.23
  7. Yi Li · 1 shared paper, 2025 · strength 0.23
  8. Bowen Xu · 1 shared paper, 2024 · strength 0.20
  9. Chang Liu · 2 shared papers, 2017–2019 · strength 0.16
  10. Guanghui Zhu · 1 shared paper, 2022 · strength 0.14
  11. Zheng Wang · 1 shared paper, 2019 · strength 0.10
  12. Hui-Ming Chen · 1 shared paper, 2019 · strength 0.10
  13. Peitong Zhang · 1 shared paper, 2018 · strength 0.09
  14. Meng Li · 1 shared paper, 2018 · strength 0.09
  15. Jichao Wei · 1 shared paper, 2017 · strength 0.06
  16. Zheng Wu · 1 shared paper, 2017 · strength 0.06
  17. Zheng Wang · 1 shared paper, 2017 · strength 0.06
  18. Kai Qu · 1 shared paper, 2017 · strength 0.06
  19. Zhixin Wang · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.